Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone

Nidia Quillinan, Elaine K. Lau, Michael Virk, Mark Von Zastrow, John Williams

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Chronic treatment with morphine results in a decrease in μ-opioid receptor sensitivity, an increase in acute desensitization, and a reduction in the recovery from acute desensitization in locus ceruleus neurons. With acute administration, morphine is unlike many other opioid agonists in that it does not mediate robust acute desensitization or induce receptor trafficking. This study compares μ-opioid receptor desensitization and trafficking in brain slices taken from rats treated for 6-7 d with a range of doses of morphine (60, 30, and 15 mg·kg-1·d-1) and methadone (60, 30, and 5 mg·kg-1·d-1) applied by subcutaneous implantation of osmotic mini-pumps. Mice were treated with 45 mg·kg-1·d-1. In morphine-treated animals, recovery from acute [Met]5enkephalin-induced desensitization and receptor recycling was diminished. In contrast, recovery and recycling were unchanged in slices from methadone-treated animals. Remarkably the reduced recovery from desensitization and receptor recycling found in slices from morphine-treated animals were not observed in animals lacking β-arrestin-2. Furthermore, pharmacological inhibition of G-protein receptor kinase 2 (GRK2), although not affecting the ability of [Met]5enkephalin to induce desensitization, acutely reversed the delay in recovery from desensitization produced by chronic morphine treatment. These results characterize a previously unidentified function of the GRK/arrestin system in mediating opioid regulation in response to chronic morphine administration. They also suggest that the GRK/arrestin system, rather than serving as a primary mediator of acute desensitization, controls recovery from desensitization by regulating receptor reinsertion to the plasma membrane after chronic treatment with morphine. The sustained GRK/arrestin-dependent desensitization is another way in which morphine and methadone are distinguished.

Original languageEnglish (US)
Pages (from-to)4434-4443
Number of pages10
JournalJournal of Neuroscience
Volume31
Issue number12
DOIs
StatePublished - Mar 23 2011

Fingerprint

Methadone
Opioid Receptors
Morphine
Arrestin
Opioid Analgesics
Cyclic GMP-Dependent Protein Kinases
Locus Coeruleus
Recycling
Cell Membrane
Pharmacology
Neurons
Brain

ASJC Scopus subject areas

  • Neuroscience(all)
  • Medicine(all)

Cite this

Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone. / Quillinan, Nidia; Lau, Elaine K.; Virk, Michael; Von Zastrow, Mark; Williams, John.

In: Journal of Neuroscience, Vol. 31, No. 12, 23.03.2011, p. 4434-4443.

Research output: Contribution to journalArticle

Quillinan, Nidia ; Lau, Elaine K. ; Virk, Michael ; Von Zastrow, Mark ; Williams, John. / Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone. In: Journal of Neuroscience. 2011 ; Vol. 31, No. 12. pp. 4434-4443.
@article{95ccaff77c1a4f1f86ca4748e5b037f2,
title = "Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone",
abstract = "Chronic treatment with morphine results in a decrease in μ-opioid receptor sensitivity, an increase in acute desensitization, and a reduction in the recovery from acute desensitization in locus ceruleus neurons. With acute administration, morphine is unlike many other opioid agonists in that it does not mediate robust acute desensitization or induce receptor trafficking. This study compares μ-opioid receptor desensitization and trafficking in brain slices taken from rats treated for 6-7 d with a range of doses of morphine (60, 30, and 15 mg·kg-1·d-1) and methadone (60, 30, and 5 mg·kg-1·d-1) applied by subcutaneous implantation of osmotic mini-pumps. Mice were treated with 45 mg·kg-1·d-1. In morphine-treated animals, recovery from acute [Met]5enkephalin-induced desensitization and receptor recycling was diminished. In contrast, recovery and recycling were unchanged in slices from methadone-treated animals. Remarkably the reduced recovery from desensitization and receptor recycling found in slices from morphine-treated animals were not observed in animals lacking β-arrestin-2. Furthermore, pharmacological inhibition of G-protein receptor kinase 2 (GRK2), although not affecting the ability of [Met]5enkephalin to induce desensitization, acutely reversed the delay in recovery from desensitization produced by chronic morphine treatment. These results characterize a previously unidentified function of the GRK/arrestin system in mediating opioid regulation in response to chronic morphine administration. They also suggest that the GRK/arrestin system, rather than serving as a primary mediator of acute desensitization, controls recovery from desensitization by regulating receptor reinsertion to the plasma membrane after chronic treatment with morphine. The sustained GRK/arrestin-dependent desensitization is another way in which morphine and methadone are distinguished.",
author = "Nidia Quillinan and Lau, {Elaine K.} and Michael Virk and {Von Zastrow}, Mark and John Williams",
year = "2011",
month = "3",
day = "23",
doi = "10.1523/JNEUROSCI.4874-10.2011",
language = "English (US)",
volume = "31",
pages = "4434--4443",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "12",

}

TY - JOUR

T1 - Recovery from μ-opioid receptor desensitization after chronic treatment with morphine and methadone

AU - Quillinan, Nidia

AU - Lau, Elaine K.

AU - Virk, Michael

AU - Von Zastrow, Mark

AU - Williams, John

PY - 2011/3/23

Y1 - 2011/3/23

N2 - Chronic treatment with morphine results in a decrease in μ-opioid receptor sensitivity, an increase in acute desensitization, and a reduction in the recovery from acute desensitization in locus ceruleus neurons. With acute administration, morphine is unlike many other opioid agonists in that it does not mediate robust acute desensitization or induce receptor trafficking. This study compares μ-opioid receptor desensitization and trafficking in brain slices taken from rats treated for 6-7 d with a range of doses of morphine (60, 30, and 15 mg·kg-1·d-1) and methadone (60, 30, and 5 mg·kg-1·d-1) applied by subcutaneous implantation of osmotic mini-pumps. Mice were treated with 45 mg·kg-1·d-1. In morphine-treated animals, recovery from acute [Met]5enkephalin-induced desensitization and receptor recycling was diminished. In contrast, recovery and recycling were unchanged in slices from methadone-treated animals. Remarkably the reduced recovery from desensitization and receptor recycling found in slices from morphine-treated animals were not observed in animals lacking β-arrestin-2. Furthermore, pharmacological inhibition of G-protein receptor kinase 2 (GRK2), although not affecting the ability of [Met]5enkephalin to induce desensitization, acutely reversed the delay in recovery from desensitization produced by chronic morphine treatment. These results characterize a previously unidentified function of the GRK/arrestin system in mediating opioid regulation in response to chronic morphine administration. They also suggest that the GRK/arrestin system, rather than serving as a primary mediator of acute desensitization, controls recovery from desensitization by regulating receptor reinsertion to the plasma membrane after chronic treatment with morphine. The sustained GRK/arrestin-dependent desensitization is another way in which morphine and methadone are distinguished.

AB - Chronic treatment with morphine results in a decrease in μ-opioid receptor sensitivity, an increase in acute desensitization, and a reduction in the recovery from acute desensitization in locus ceruleus neurons. With acute administration, morphine is unlike many other opioid agonists in that it does not mediate robust acute desensitization or induce receptor trafficking. This study compares μ-opioid receptor desensitization and trafficking in brain slices taken from rats treated for 6-7 d with a range of doses of morphine (60, 30, and 15 mg·kg-1·d-1) and methadone (60, 30, and 5 mg·kg-1·d-1) applied by subcutaneous implantation of osmotic mini-pumps. Mice were treated with 45 mg·kg-1·d-1. In morphine-treated animals, recovery from acute [Met]5enkephalin-induced desensitization and receptor recycling was diminished. In contrast, recovery and recycling were unchanged in slices from methadone-treated animals. Remarkably the reduced recovery from desensitization and receptor recycling found in slices from morphine-treated animals were not observed in animals lacking β-arrestin-2. Furthermore, pharmacological inhibition of G-protein receptor kinase 2 (GRK2), although not affecting the ability of [Met]5enkephalin to induce desensitization, acutely reversed the delay in recovery from desensitization produced by chronic morphine treatment. These results characterize a previously unidentified function of the GRK/arrestin system in mediating opioid regulation in response to chronic morphine administration. They also suggest that the GRK/arrestin system, rather than serving as a primary mediator of acute desensitization, controls recovery from desensitization by regulating receptor reinsertion to the plasma membrane after chronic treatment with morphine. The sustained GRK/arrestin-dependent desensitization is another way in which morphine and methadone are distinguished.

UR - http://www.scopus.com/inward/record.url?scp=79953003987&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953003987&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.4874-10.2011

DO - 10.1523/JNEUROSCI.4874-10.2011

M3 - Article

VL - 31

SP - 4434

EP - 4443

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 12

ER -